Automation, Digitization, and Robotics in Cell and Gene Therapy
Automation, Digitization, and Robotics in Cell and Gene Therapy
https://www.openpr.com/news/4485699/automation-digitization-and-robotics-in-cell-and-gene-therapy
Publish Date: 2026-04-23 08:27:00
Source Domain: www.openpr.com
- The global market for automation, digitization, and robotics in cell and gene therapy manufacturing is projected to grow from USD 950 million in 2025 to USD 5.28 billion by 2035, with a CAGR of 18.70% from 2026 to 2035.
- Key drivers of this growth include the adoption of advanced manufacturing technologies, rising regulatory compliance, and the commercialization of advanced therapies.
- Artificial Intelligence (AI) enhances precision and efficiency in the production of cell and gene therapies, optimizing every phase of manufacturing.
- Significant regional markets include North America, Europe, and Asia Pacific, each driven by advanced infrastructure, government support, and burgeoning healthcare demands.
- Market segments highlight technology types, automation levels, applications, end-use, and regional breakdowns, with key players like Thermo Fisher Scientific Inc. and Sartorius AG leading the industry.
